NCT07412132: Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II.
- State
- Under way
- Phase
- Phase 3
- People
- 40 planned
- Started
- 9 Jan 2026
- Primary completion
- Jan 2027
- Arms
- Active Group
- Results
- None posted
- 9 Jan 2026: Trial started
- 17 Feb 2026: Trial registered